Вы находитесь на странице: 1из 8

Journal of Experimental Botany, Vol. 50, No. 332, pp.

275282, March 1999


Brassinosteroid actions in plants

Jianming Li and Joanne Chory1
Howard Hughes Medical Institute, Plant Biology Laboratory, The Salk Institute for Biological Studies,
10010 N. Torrey Pines Road, La Jolla, CA 92037, USA
Received 8 July 1998; Accepted 6 October 1998


Key words: Brassinosteroid, biosynthesis, signal transduction, dwarf, receptor kinase.

Steroid hormones are crucial for embryonic development
and adult homeostasis in animals (Evans, 1988).
Similarly, the insect steroid hormone, ecdysone, triggers
a key regulatory cascade of gene expression controlling
many developmental processes such as moulting,
metamorphosis and reproduction ( Thummel, 1995). In
plants, many steroids have been identified, but only one
class of steroids, called collectively brassinosteroids, have
wide distribution throughout the plant kingdom and
unique growth-promoting activity when applied exogenously (Mandava, 1988; Fujioka and Sakurai, 1997).
Physiological studies done in several laboratories have
demonstrated that brassinosteroids can induce a broad
spectrum of cellular responses such as stem elongation,

1 To whom correspondence should be addressed. Fax: +1 619 558 6379. E-mail: chory@salk.edu
Oxford University Press 1999

Downloaded from jxb.oxfordjournals.org by guest on December 23, 2010

Recent studies on dwarf mutants of Arabidopsis,

tomato and pea have provided convincing evidence
that brassinosteroids are a unique class of plant hormones that are essential for normal plant growth.
Detailed metabolic analyses of these mutants, coupled
with thorough molecular and biochemical studies of
their corresponding genes and gene products, are
essential for a better understanding of brassinosteroid
biosynthesis and its regulation. Molecular and genetic
approaches have been undertaken to dissect the
brassinosteroid signalling pathway, leading to the
identification of a putative brassinosteroid receptor
and a few brassinosteroid-response genes. Further
studies should expand our knowledge on how brassinosteroids are perceived and transduced to regulate
plant development.

pollen tube growth, leaf bending and epinasty, root

inhibition, induction of ethylene biosynthesis, protonpump activation, xylem differentiation, and regulation of
gene expression (Mandava, 1988; Clouse and Sasse,
1998). In addition, useful agricultural applications have
been found such as increasing yield and improving stress
resistance of several major crop plants (Cutler et al.,
1991). Despite this extensive research, a definitive proof
that these steroids are essential for normal plant growth
has been lacking.
A clear role for these steroids in plant growth and
development came from an entirely different field of
studies: genetic analysis of plant photomorphogenesis. In
plants, immediate post-germinative growth usually occurs
beneath the soil surface and newly germinated seedlings
need to bring their leaves into full sunlight so that they
can start photosynthesis to provide the essential raw
materials needed for long-term growth. An etiolated
seedling, with an apical hook, closed cotyledons, and a
rapidly elongating hypocotyl, can reach the soil surface
quickly without damaging its young leaves. Once the
seedling is in full sunlight, its growth pattern changes:
the cotyledons expand and new leaves develop, accompanied by the induction of many genes involved in photosynthetic function, while the hypocotyl, whose elongation
is dramatically inhibited, becomes thicker and acts as a
physical support to hold newly developed leaves. Such a
developmental switch from one suited to an underground
environment to one suited to full sunlight is often referred
to as photomorphogenesis, or de-etiolation (Cosgrove,
In order to understand the molecular mechanisms
regulating this process, a genetic screen was initiated to
identify Arabidopsis mutants that display many characteristics of light-grown plants when grown in the dark
(Chory et al., 1989). So far, mutants of over 18 loci have
been isolated and characterized ( Wei and Deng, 1996).

276 Li and Chory

Among these mutants are recessive alleles of a gene
called DET2. Loss of-function mutations in DET2 have
pleiotropic effects on Arabidopsis development (Chory
et al., 1991). In the dark, det2 mutants are short, have
thick hypocotyls, accumulate anthocyanins, have open,
expanded cotyledons, develop primary leaf buds, and
inappropriately express light-regulated genes. In the light,
det2 mutants are dark-green dwarfs, have reduced apical
dominance and male fertility, display altered photoperiodic responses, show delayed chloroplast and leaf
senescence, and respond improperly to fluctuations in
their light environment. Such phenotypic differences
between det2 mutants and wild-type Arabidopsis plants
indicate that DET2 plays an important role throughout
Arabidopsis development.

Brassinosteroid biosynthesis

Downloaded from jxb.oxfordjournals.org by guest on December 23, 2010

DET2 encodes a protein that exhibits significant sequence

identity with mammalian steroid 5a-reductases that are
involved in animal steroid metabolism (Li et al., 1996).
In addition, a conservative substitution of a glutamate
(Glu204), which is absolutely conserved among all
mammalian steroid 5a-reductases and is essential for the
activity of a type 2 human 5a-reductase (Russell and
Wilson, 1994), completely abolishes the in vivo activity
of DET2 protein, strongly suggesting that DET2 might
be involved in the biosynthesis of plant steroids such as
brassinosteroids. Consistent with this hypothesis, brassinosteroid treatment rescued the growth defects of both
dark and light-grown det2 mutants (Li et al., 1996;
Fujioka et al., 1997). When expressed in mammalian
cells, DET2 protein was able to 5a-reduce several animal
steroids including testosterone and progesterone.
Moreover, the expression of human genes encoding
steroid 5a-reductases complemented a det2 mutation,
demonstrating that DET2 is a functional homologue of
mammalian steroid 5a-reductases (Li et al., 1997). det2
mutants accumulated only 815% of the wild-type level
of campestanol and less than 10% of the wild-type levels
of other brassinosteroids and failed to convert 2H-labelled
campesterol to 2H-labelled campestanol, showing that
det2 is a brassinosteroid-deficient mutant. A further proof
came from rescue experiments in which all intermediates
of the brassinosteroid biosynthetic pathway after the
DET2 reaction were capable of rescuing det2 mutant
phenotypes. Taken together, these results establish that
DET2 is a brassinosteroid biosynthetic enzyme catalysing
an early step in the brassinosteroid biosynthetic pathway
(Fig. 1; Fujioka et al., 1997).
In addition to the DET2 gene, there are several putative
brassinosteroid biosynthetic genes that have been cloned
recently in Arabidopsis. Both CPD and DWF4 encode
cytochrome P450 proteins that share sequence similarities
with mammalian steroid hydroxylases and feeding experi-

ments with various brassinosteroids suggest that they act

at the C-23 and C-22 hydroxylation steps, respectively,
in the biosynthetic pathway ( Fig. 1; Szekeres et al., 1996;
Choe et al., 1998a). Both CBB3 ( Kauschmann et al.,
1996) and DWF3 (Choe et al., 1998b) are allelic to CPD.
The Arabidopsis DWF1/DIM1/CBB1 protein ( Feldmann
et al., 1989; Takahashi et al., 1995; Kauschmann et al.,
1996) has strong homology with several unknown
proteins of pea, human, and C. elegans (J. Li and
J. Chory, unpublished data), and is suggested to be an
FAD-dependent oxidoreductase (Mushegian and Koonin,
1995). Quantitative analysis of endogenous brassinosteroid levels in dim1 mutants suggests that the
dim1 mutation might block the conversion of
24-methylenecholesterol to campesterol (Fig. 1; Clouse
and Sasse, 1998). Mutations in each of these genes result
in phenotypes that are very similar to those of det2
mutants and these mutants can also be rescued by brassinosteroid treatment. Given the fact that mutations in
each of these genes affect many aspects of light-regulated
Arabidopsis development, the recent molecular genetic
analyses of these dwarf mutants have provided convincing
evidence that brassinosteroids are a unique class of plant
hormones that are essential for normal plant growth and
The identification of additional brassinosteroiddeficient dwarf mutants in both Arabidopsis and other
plant species further confirms the importance of these
steroids in plant development. Three novel Arabidopsis
dwarf mutants including dwf5, dwf7 and dwf8 were
recently found to be defective in brassinosteroid biosynthesis (Choe et al., 1998b). Results from feeding
experiments and analyses of endogenous brassinosteroid
levels have indicated that both dwf5 and dwf7 mutants
are defective in the formation of 24-methylenecholesterol,
a precursor to campesterol, while the dwf8 mutation is
suggested to block a late step after 3-dehydroteasterone
in the brassinolide biosynthetic pathway (Fig. 1; Choe
et al., 1998b). The lkb mutant of pea is a brassinosteroiddeficient dwarf that shows normalization of internode
elongation upon application of a range of brassinosteroids
(Nomura et al., 1997) and a recent study suggested that
the lkb mutation, like the Arabidopsis dim1 mutation,
blocks the conversion of 24-methylenecholesterol to campesterol (Fig. 1; Clouse and Sasse, 1998). Another pea
mutant, lk, is believed to be defective in the conversion
of campesterol to campestanol and the corresponding
gene LK might encode a pea homologue of the Arabidopsis
DET2 ( Fig. 1; Yokota et al., 1997). The DWARF gene of
tomato was recently cloned by transposon tagging and
shown to encode a cytochrome P450 with 38% sequence
identity to the Arabidopsis CPD (Bishop et al., 1996).
Preliminary feeding experiments suggest that the tomato
DWARF is also a brassinosteroid biosynthetic enzyme,
acting later in the biosynthetic pathway than CPD (Clouse

Brassinosteroid action in plants 277

Downloaded from jxb.oxfordjournals.org by guest on December 23, 2010

Fig. 1. Proposed pathways for brassinolide biosynthesis. The early C-6 oxidation pathway is on the left side and the late C-6 oxidation pathway is
on the right side. Steps of phytosterol biosynthesis leading to the formation of campesterol are included and known mutations that block either
biosynthesis of or response to brassinosteroids are indicated ( X ). Question marks indicate uncertainty about exact biochemical lesions and the
broken arrows denote mutilple steps. This diagram is adopted from Clouse and Sasse (1998) and Choe et al. (1998a).

278 Li and Chory

developmental signals. Feeding experiments using det2
and dwf4 mutants have consistently shown that brassinosteroids in the late C-6 oxidation pathway are more
effective in rescuing light phenotypes whereas the brassinosteroids in the early C-6 oxidation pathways show
stronger activity in promoting hypocotyl elongation of
dark-grown seedlings (Fujioka et al., 1997; Choe et al.,
1998a). Further measurements of endogenous brassinosteroid intermediates of different subpathways and detailed
analysis of expression patterns of key brassinosteroid
biosynthetic genes under different environmental conditions or at different developmental stages should help to
understand the regulation of brassinosteroid biosynthesis.
Metabolic studies with wild-type Arabidopsis and det2
seedlings indicate that the reaction catalysed by DET2 is
a major rate-limiting step in the brassinosteroid biosynthetic pathway (S Fujioka, personal communication).
Consistent with such an observation, overexpression of
DET2 in Arabidopsis results in transgenic plants that are
significantly larger than wild-type plants in the light, while
underexpression of DET2 using an antisense DET2
construct leads to an allelic series of plants ranging from
det2-like dwarfs to wildtype in stature (Chory and Li,
1997). These results support the early claims that brassinosteroid applications could increase crop productivity.
Likewise, the 22-hydroxylation reaction has also been
hypothesized to be a rate-limiting step (Fujioka et al.,
1995). Therefore, DWF4 might be another limiting activity in the biosynthesis of brassinolide (Choe et al., 1998a).
Biochemical, metabolic and transgenic studies are needed
to confirm whether DWF4 does catalyse a rate-limiting
reaction in the brassinosteroid biosynthetic pathway. If
so, it will be interesting to see whether overexpression of
both DET2 and DWF4 genes will have a great effect on
the biomass of transgenic plants.
Analysing the expression of the cloned brassinosteroid
biosynthetic genes can provide hints to where brassinosteroids are synthesized and how brassinosteroid biosynthesis is regulated. DET2 appears to be constitutively
and ubiquitously expressed throughout Arabidopsis development and in response to different light conditions (Li
and Chory, 1997; D Friedrichsen and J Chory, unpublished observations). In contrast, the expression of CPD
is confined to cotyledon and leaf primordia in dark-grown
seedlings and the adaxial parenchyma of expanding leaves
in light-grown plants. CPD expression is not detected in
either actively elongating cells of hypocotyls and roots,
or pollen and seeds where the highest brassinolide levels
have been detected (Mathur et al., 1998). Such an expression pattern of CPD might suggest that brassinosteroids
are synthesized in both cotyledons and leaves and are
then transported to the organs that require high levels of
brassinosteroids for normal growth. Alternatively, there
might be enzymatic machineries that reduce the levels of
active brassinosteroids to relieve a feedback inhibition on

Downloaded from jxb.oxfordjournals.org by guest on December 23, 2010

and Sasse, 1998). Another tomato mutant, dpy, was

found to be deficient in C-23 hydroxylation of both
cathasterone and 6-deoxocathasterone, implying that
DPY is the tomato homologue of CPD (Fig. 1; Clouse
and Sasse, 1998).
The brassinosteroid-deficient mutants and the cloned
brassinosteroid-biosynthetic genes provide an important
tool for investigating not only the physiological functions
but also the biosynthetic pathways of brassinosteroids.
The detailed metabolic analyses of det2 mutants coupled
with the biochemical characterization of DET2 protein
aided the identification of a 3-oxo, D45 steroid,
3-dehydro-D45-campesterol, as a direct substrate of the
DET2 reductase ( Fig. 1; Li et al., 1997; Fujioka et al.,
1997). Such a study also concluded that Arabidopsis
must have a plant orthologue of the mammalian
isomerases to catalyse the conversion of campesterol to
3-dehydro-D45-campesterol and the conversion of
3-dehydrocampestanol to campestanol (Fig. 1). Indeed,
recent database searches indicate that the Arabidopsis
genome contains at least two genes for such an enzyme
(J Li and J Chory, unpublished results). Quantitative
analysis of campestanol levels in three presumed null
alleles of det2 has suggested that there is a second steroid
5a-reductase in Arabidopsis that plays a minor role in
brassinosteroid biosynthesis ( Fujioka et al., 1997), which
might explain the relatively weak phenotypes of det2
mutants compared to cpd/cbb3/dwf3 mutants. Further
molecular and genetic studies should aid in the identification of this second reductase and the elucidation of its
physiological function during plant development.
The existence of various brassinosteroid-deficient mutants allowed the testing of the possibility that brassinolide
is not synthesized via a simple linear biosynthetic pathway. Recently, two pathways, the so-called early C-6
oxidation and late C-6 oxidation pathways, were proposed
for the biosynthesis of brassinolide ( Fig. 1; Fujioka and
Sakurai, 1997). Feeding experiments with intermediates
of both pathways provided strong genetic evidence that
both pathways are operating in Arabidopsis (Fujioka
et al., 1997; Choe et al., 1998a). A recent study with dwf4
mutants suggests that 22-hydroxyl-campesterol might be
a starting point for a new subpathway since this compound is able to rescue dwf4 mutations (Choe et al.,
1998a). Similarly, 6a-hydroxycampesterol could also be
a starting point for a different subpathway whose intermediates act as bridging molecules between the early
and late C-6 oxidation pathways (Choe et al., 1998a).
Identification of new brassinosteroid biosynthetic intermediates in vivo are needed to confirm whether these
hypothesized subpathways exist in plants. One simple
explanation for plants having multiple pathways of brassinosteroid biosynthesis is that these subpathways might
be differentially regulated by various environmental or

Brassinosteroid action in plants 279

CPD expression in either cotyledons or expanding leaves.
Several different enzyme reactions have been implicated
in brassinosteroid inactivation such as hydroxylation,
glycosylation, acylation, and side-chain degradation
(Fujioka and Sakurai, 1997; Adam et al., 1996). Both
the transport and metabolism of 14C-labelled
24-epibrassinolide have been studied in cucumber and
wheat seedlings ( Fujioka and Sakurai, 1997). When
applied to roots, 24-epibrassinolide is readily taken up
and transported to leaves; in contrast, when applied to
leaves, its transport is quite slow. It was later shown that
this compound is quickly metabolized in leaves, but
not in hypocotyls and roots. As such, these results are
consistent with the second hypothesis.

Brassinosteroid signal transduction

Downloaded from jxb.oxfordjournals.org by guest on December 23, 2010

Having established the essential role of brassinosteroids

in plant growth and development, the most interesting
question to ask is how plants recognize these steroids and
transduce their signals to regulate a wide spectrum of
developmental processes. To understand the molecular
mechanism by which brassinosteroids regulate plant
development, it is necessary to identify components of
the brassinosteroid response pathway, including receptor(s), intermediates, and targets. Currently, both molecular and genetic approaches have been taken to investigate
the molecular mechanisms of brassinosteroid signalling.
The molecular approach is to clone brassinosteroidregulated genes, understand their functions, map their
corresponding brassinosteroid-responsive cis-acting elements and identify trans-acting regulatory factors mediating brassinosteroid-regulated gene expression. It has been
demonstrated that brassinosteroid-induced responses
require de novo protein synthesis (Mandava, 1988) and
brassinosteroid-treatment induces synthesis of both
mRNAs and proteins (Clouse, 1996). Using a differential
hybridization method, a brassinosteroid up-regulated
(BRU1) gene was identified from elongating soybean
epicotyls (Zurek and Clouse, 1994). BRU1 encodes a
protein that showed significant homology to various
xyloglucan endotransglycosylases ( XETs) which have
been implicated in cell wall loosening during cell
elongation (Clouse, 1996). A later study proved that
BRU1 is indeed a functional XET (Oh et al., 1998). The
expression level of BRU1 correlates with the extent of
brassinosteroid-promoted stem elongation and the accumulation of the BRU1 transcript parallels the brassinosteroid-mediated increases in plastic extensibility of the
cell wall (Zurek and Clouse, 1994; Zurek et al., 1994).
Moreover, a linear relationship has been observed
between brassinosteroid concentrations and extractable
XET activities in brassinosteroid treated soybean epicotyls (Oh et al, 1998), strongly suggesting an involvement
of BRU1 in brassinosteroid-stimulated stem elongation.

Surprisingly, brassinosteroid regulates BRU1 expression

at a post-transcriptional rather than a transcriptional
level (Zurek and Clouse, 1994). A brassinosteroidregulated XET has also been identified in Arabidopsis
( Xu et al., 1995). The TCH4 gene encodes an XET whose
expression is increased within 30 min of brassinosteroid
treatment, with a maximum at 2 h. In addition to brassinosteroids, this gene is also regulated by touch, darkness,
temperature shock and auxin. In contrast to soybean
BRU1, the brassinosteroid-regulated TCH4 expression
occurs at the transcriptional level ( Xu et al., 1995). The
brassinosteroid-responsive element has been mapped to a
100 bp fragment of the TCH4 promoter (Clouse and
Sasse, 1998) and linker-scanning mutagenesis is underway
to identify the specific brassinosteroid response element(s)
for this gene.
A recent study has shown that expression of CPD is
specifically down-regulated by brassinolide although its
transcription is not affected by other plant hormones
including auxin, ethylene, gibberellin, cytokinin, jasmonic
acid, and salicylic acid (Mathur et al., 1998). Such a
brassinosteroid-induced repression of CPD transcription
is sensitive to the protein synthesis inhibitor cycloheximide, indicating a requirement for de novo synthesis
of a negative transcriptional regulator (Mathur et al.,
1998). Mapping of brassinosteroid-response element(s) in
the CPD promoter is necessary to find transcriptional
factors regulating CPD gene expression.
The genetic approach to the identification of components of the brassinosteroid signalling pathway is the
isolation and characterization of Arabidopsis mutants
deficient in brassinosteroid responses. Screens for
hormone-insensitive mutants in Arabidopsis have proven
to be fruitful in the study of plant hormone action. As
examples, screens for mutants that are insensitive to high
levels of exogenously applied auxins, ethylene, gibberellins, and abscisic acid have led to the identification of
loci involved in signalling from these plant hormones.
Among the ethylene-insensitive loci are ETR1 and ETR2,
which encode ethylene receptors (Chang et al., 1993;
Sakai et al., 1998).
An Arabidopsis brassinosteroid-insensitive mutant
(bri1) was originally identified by a root-growth inhibition
assay (Clouse et al., 1996). bri1 seedlings display similar
pleiotropic phenotypes to brassinosteroid-deficient
mutants, yet can not be rescued by brassinosteroid treatment. The bri1 mutants showed marked insensitivity only
to brassinosteroids but retain complete sensitivities to
auxins, cytokinins, gibberellins, abscisic acid, and
ethylene. A second brassinosteroid insensitive mutant
cbb2, has been isolated independently in a genetic screen
for cabbage-like Arabidopsis mutants ( Kauschmann et al.,
1996) and was later found to be allelic to bri1.
Brassinosteroid insensitivity in the cbb2 mutant has also
been observed at the molecular level. The brassinosteroid-

280 Li and Chory

that regulate gene expression (Beato et al., 1995); however, cell surface steroid receptors are known to be present
in animal cells mediating non-genomic effects of steroid
hormones (McEwen, 1991) and protein tyrosine phosphorylation has been implicated in such a membraneinitiated steroid signalling pathway (Tesarik et al., 1993;
Mendoza et al., 1995).
Second, while many LRR-containing proteins are
involved in signal transduction pathways, LRRs are
believed to mediate proteinprotein interactions and, in
many cases, provide binding sites for protein ligands
( Kobe and Deisenhofer, 1994). So far, no LRR has ever
been found to interact with small compounds.
Interestingly enough, the predicted BRI1 protein contains
a unique 70 amino-acid island buried between the 21st
and 22nd LRRs. The importance of this island in BRI1s
function is self-evident by sequencing two bri1 alleles,
both of which have a missense mutation in this domain
(Li and Chory, 1997; J. Li and J. Chory, unpublished
results). In contrast, of 19 bri1 alleles that have been
sequenced, no allele contains a mutation in the LRRs
themselves. It is worthwhile to note that mutations in
LRRs have been identified in both erecta and clv1 alleles
( Torri et al., 1996; Clark et al., 1997). Careful biochemical
studies are needed to determine whether BRI1 is a
brassinosteroid receptor, and if so, whether the island is
directly involved in binding brassinosteroids.
BRI1s kinase domain must be essential for the BRI1s
function. Of the 19 bri1 alleles sequenced to date, 15 have
mutations in this domain (Li and Chory, 1997; J. Li and
J. Chory, unpublished results). This domain must interact
with other downstream signalling components to transduce the steroid signal. One protein that might interact
with BRI1s kinase domain is a type 2C phosphatase
( KAPP) which has been implicated to be involved in
both RLK5 and CLV1-mediated signalling pathways
(Stone et al., 1994; Williams et al., 1997). Indeed, a fusion
protein between glutathione S-transferase (GST ) and
BRI1s kinase domain interacts with this phosphatase in
vitro (J. Li and J. Chory, unpublished results). Transgenic
experiments are underway to find the physiological
relevance of such an interaction.

Conclusion and perspectives

To understand completely how brassinosteroids act in
plants, more components of the brassinosteroid response
pathways need to be isolated and characterized. It might
be possible to identify proteins involved in brassinosteroid
signal transduction that directly interact with BRI1s
kinase domain by a yeast two-hybrid screening or interactive cloning strategy. Although four different genetic
screenings have resulted in the identification of only one
brassinosteroid signalling component, BRI1, at least two
other genetic screens can be used to identify new compon-

Downloaded from jxb.oxfordjournals.org by guest on December 23, 2010

induced expression of two XET genes, TCH4 and meri5,

is missing in the mutant, although GA-induced meri5
expression is still observed ( Kauschmann et al., 1996). A
different genetic screen, designed specifically for brassinosteroid-response mutants with brassinosteroid-deficient
phenotypes, has also been performed. The screen involved
two steps: a primary screen for det2 or cpd-like dwarf
mutants followed by a secondary screen for dwarfism
that could not be rescued by brassinosteroid treatment.
This screen yielded 18 bin (brassinosteroid insensitive)
mutants that were later found to be new alleles of the
BRI1/CBB2 locus. Recently, three dwf2 alleles were found
to be allelic to bri1 (Clouse and Sasse, 1998) and two
new bri1 alleles were identified from a collection of dwarf
mutants at the Arabidopsis Biological Resource Center
( The Ohio State University, Ohio, USA) and a private
collection of T-DNA insertion lines (J. Li and J. Chory,
unpublished data), thus bringing the total number of bri1
alleles to 25. It is somewhat surprising that all brassinosteroid-insensitive mutants isolated in four different genetic
screens are all alleles of a single gene. This suggests that
BRI1 is the only unique and specific component in the
brassinosteroid signalling pathway and other components
of the pathway are either redundant (mutants would have
no obvious phenotype) or shared with other signalling
cascades (mutants would be lethal ). Brassinosteroidinsensitive mutants have also been identified in both pea
(lka, Nomura et al., 1997) and tomato (cu-3, Clouse and
Sasse, 1998) ( Fig. 1).
The almost identical phenotypes between bri1 and cpd,
the most severe brassinosteroid-deficient mutant isolated
to date, strongly suggests that BRI1 encodes an early
component of the brassinosteroid response pathway, most
likely a brassinosteroid receptor. Recently, the Arabidopsis
BRI1 gene was cloned by chromosome walking (Li and
Chory, 1997) and found to encode a protein that has
significant sequence identity to a family of plant leucinerich-repeat (LRR) receptor-like kinases including Xa21
of rice (Song et al., 1995), ERECTA and CLV1 of
Arabidopsis ( Torii et al., 1996; Clark et al., 1997). The
predicted BRI1 protein contains several distinct domains:
a signal peptide, a putative leucine-zipper motif, 25
leucine-rich-repeats, a 70 amino-acid island buried
between the 21st and 22nd LRR, and a cytoplasmic
kinase domain that has serine/threnine kinase activity
when expressed in E. coli or animal cells (J Li, C
Joazeiro and J Chory, unpublished data).
The finding that BRI1 is a LRR-containing receptor
kinase is quite a surprise. First, while a transmembrane
receptor kinase is a central theme in many signal transduction events ( Ullrich and Schlessinger, 1990), no such
receptor kinase has ever been found to be involved in a
steroid signal transduction pathway. All known steroid
receptors belong to a superfamily of nuclear receptor
proteins that are ligand-dependent transcription factors

Brassinosteroid action in plants 281

ents involved in brassinosteroid signal transduction. One
is a transgene-based screening using a well-characterized
brassinosteroid-regulated promoter fused to a reporter
gene. Such a genetic screen has been used successfully to
identify mutants affecting phytochrome responses and
chloroplast-nuclear communication (Li et al., 1994, 1995;
Susek et al., 1993). The other screen is to identify mutants
that suppress or enhance either brassinosteroid-deficient
or brassinosteroid-response mutations. Results from these
studies will certainly expand our knowledge of how
steroids regulate plant development. A better understanding of the brassinosteroid signal transduction pathway
will make it possible to manipulate plant growth genetically in order to improve crop productivity.


Adam G, Porzel A, Schmidt J, Schneider B, Voigt B. 1996. New
developments in brassinosteroid research. In: Atta-ur
Rahman, ed. Studies in natural products chemistry, Vol. 18.
Amsterdam: Elsevier, 495549.
Beato M, Herrlich P, Schutz G. 1995. Steroid hormone
receptors: many actors in search of a plot. Cell 83, 851857.
Bishop GJ, Harrison K, Jones JDG. 1996. The tomato dwarf
gene isolated by heterologous transposon tagging encodes the
first member of a new cytochrome P450 family. The Plant
Cell 8, 959969.
Chang C, Kwok SF, Bleecker AB, Meyerowitz EM. 1993.
Arabidopsis ethylene-response gene ETR1: similarity of
product to two-component regulators. Science 262, 539544.
Choe S, Dilkes BP, Fujioka S, Takatsuto S, Sakurai A, Feldmann
KA. 1998a. The DWF4 gene of Arabidopsis encodes a
cytochrome P450 that mediates mutiple 22a-hydroxylation
steps in brassinosteroid biosynthesis. The Plant Cell 10,
Choe S, Fujioka S, Tanaka A, Tissier CP, Rossa AS, Noguchi
T, Takatsuto S, Yoshidab S, Taxa FE, Feldmann KA. 1998b.
Molecular cloning of Arabidopsis brassinosteroid biosynthetic
genes DWF4, DWF5, and DWF7. In: Abstracts of the 9th
International Conference on Arabidopsis Research. University
of Wisconsin-Madison, 555.
Chory J, Li J. 1997. Gibberellins, brassinosteroids and lightregulated development. Plant, Cell and Environment 20,
Chory J, Nagpal P, Peto CA. 1991. Phenotypic and genetic
analysis of det2, a new mutant that affects light-regulated
seedling development in Arabidopsis. The Plant Cell 3,
Chory J, Peto C, Feinbaum R, Pratt L, Ausubel F. 1989.
Arabidopsis thaliana mutant that develops as a light-grown
plant in the absence of light. Cell 58, 991999.
Clark S, Williams RW, Meyerowitz EM. 1997. The CLAVATA1
gene encodes a putative receptor kinase that controls shoot
and floral meristem size in Arabidopsis. Cell 89, 575585.

Downloaded from jxb.oxfordjournals.org by guest on December 23, 2010

Work on brassinosteroids in our laboratory is supported by the

United States Department of Agriculture. JC is an investigator
of the Howard Hughes Medical Institute and JL is an American
Cancer Society postdoctoral fellow.

Clouse SD. 1996. Molecular genetic studies confirm the role of

brassinosteroids in plant growth and development. The Plant
Journal 10, 18.
Clouse SD, Langford M, McMorris TC. 1996. A brassinosteroidinsensitive mutant in Arabidopsis thaliana exhibits multiple
defects in growth and development. Plant Physiology 111,
Clouse SD, Sasse JM. 1998. Brassinosteroids: essential
regulators of plant growth and development. Annual Review
of Plant Physiology and Plant Molecular Biology 49, 427451.
Cosgrove DJ. 1986. Photomodulation of growth. In: Kendrick
RE, Kronenberg GHM, eds. Photomorphogenesis in plants.
Dordrecht: Martinus Nijhoff Publishers, 341366.
Cutler HG, Yokota T, Adam G. 1991. Brassinosteroids: chemistry,
bioactivity, and applications. ACS Symposium Series 474.
Washington DC: American Chemical Society.
Evans RM. 1988. The steroid and thyroid hormone receptor
superfamily. Science 240, 889895.
Feldmann KA, Marks MD, Christianson ML, Quatrano RS.
1989. A dwarf mutant of Arabidopsis generated by T-DNA
insertion mutagenesis. Science 243, 13511354.
Fujioka S, Inoue T, Takatsuto S, Yanagisawa T, Yokota T,
Sakurai A. 1995. Identification of a new brassinosteroid,
cathasterone, in cultured cells of Catharanthus roseus as a
biosynthetic precursor of teasterone. Bioscience, Biotechnology
and Biochemistry 59, 15431547.
Fujioka S, Li J, Choi Y-H, Seto H, Takatsuto S, Noguchi T,
Watanabe T, Kuriyama H, Yokota T, Chory J, Sakurai A.
1997. The Arabidopsis deetiolated2 mutant is blocked early in
brassinosteroid biosynthesis. The Plant Cell 9, 19511962.
Fujioka S, Sakurai A. 1997. Brassinosteroids. Natural Products
Reporter 14, 110.
Kauschmann A, Jessop A, Koncz C, Szekeres M, Willmitzer L,
Altmann T. 1996. Genetic evidence for an essential role of
brassinosteroids in plant development. The Plant Journal
9, 701713.
Kobe B, Deisenhofer J. 1994. The leucine-rich repeat: a versatile
binding domain. Trends in Biochemical Science 19, 415421.
Li H-m, Altschmied L, Chory J. 1994. Arabidopsis mutants
define downstream branches in the phototransduction
pathway. Genes Developments 8, 339349.
Li H-m, Culligan K, Dixon RA, Chory J. 1995. CUE1: a
mesophyll cell-specific positive regulator of light-controlled
gene expression in Arabidopsis. The Plant Cell 7, 15991610.
Li J, Biswas MG, Chao A, Russel DW, Chory J. 1997.
Conservation of function between mammalian and plant
steroid 5a-reductases. Proceedings of the National Academy
of Sciences, USA 94, 35543559.
Li J, Chory J. 1997. A putative leucine-rich repeat receptor
kinase involved in brassinosteroid signal transduction. Cell
90, 929938.
Li J, Nagpal P, Vitart V, McMorris TC, Chory J. 1996. A role
for brassinosteroids in light-dependent development of
Arabidopsis. Science 272, 398401.
Mandava NB. 1988. Plant growth-promoting brassinosteroids.
Annual Review of Plant Physiology and Plant Molecular
Biology 39, 2352.
Mathur, J, Molnar G, Fujioka S, Takatsuto S, Sakurai A,
Yokota T, Adam G, Voigt B, Nagy F, Maas C, Schell J,
Koncz C, Szekeres M. 1998. Transcription of the Arabidopsis
CPD gene, encoding a steroidogenic cytochrome P450, is
negatively controlled by brassinosteroids. The Plant Journal
14, 593602.
McEwen BS. 1991. Non-genomic and genomic effects of steroids
on neural activity. Trends in Pharmaceutical Science 12,

282 Li and Chory

Takahashi T, Gasch A, Nishizawa N, Chua N-H. 1995. The
DIMINUTO gene of Arabidopsis is involved in regulating cell
elongation. Genes Development 9, 97107.
Tesarik J, Moos J, Mendoza C. 1993. Stimulation of protein
tyrosine phosphorylation by a progesterone receptor on the
cell surface of human sperm. Endocrinology 133, 328335.
Thummel CS. 1995.From embryogenesis to metamorphosis: the
regulation and function of Drosophila nuclear receptor
superfamily members. Cell 83, 871877.
Torii, K, Mitsukawa N, Oosumi T, Matsuura Y, Yokoyama R,
Whittier R, Komeda Y. 1996. The Arabidopsis ERECTA gene
encodes a putative receptorj protein kinase with extracellular
leucine-rich repeats. The Plant Cell 8, 735746.
Ullrich W, Schlessinger J. 1990. Signal transduction by receptors
with tyrosine kinase activity. Cell 61, 203212.
Wei N, Deng X-W. 1996. The role of the COP/DET/FUS genes
in light control of Arabidopsis seedling development. Plant
Physiology 110, 731742.
Williams R, Wilson J, Meyerowitz EM. 1997. A possible role
for kinase-associated protein phosphatase in the Arabidopsis
CLAVATA1 signalling pathway. Proceedings of the National
Academy of Sciences, USA 94, 1046710472.
Xu W, Purugganan MM, Polisensky DH, Antosiewicz DM, Fry
SC, Braam J. 1995. Arabidopsis TCH4, regulated by hormones
and the environment, encodes a xyloglucan endotransglycosylase. The Plant Cell 7, 15551567.
Yokota T, Nomura T, Takatsuto S. 1997 Blocked synthesis of
campesterol in brassinosteroid-deficient pea mutant lkb. Plant
Physiology 115, (suppl.) 169.
Zurek DM, Clouse SD. 1994. Molecular cloning and characterization of a brassinosteroid-regulated gene from elongating
soybean (Glycine max L.) epicotyls. Plant Physiology 104,
Zurek DM, Rayle DL, McMorris TC, Clouse SD. 1994.
Investigation of gene expression, growth kinetics, and wall
extensibility during brassinosteroid-regulated stem elongation.
Plant Physiology 104, 505513.

Downloaded from jxb.oxfordjournals.org by guest on December 23, 2010

Mendoza C, Soler A, Tesarik J. 1995. Non-genomic steroid

action: independent targeting of a plasmamembrane calcium
channel and a tyrosine kinase. Biochemical and Biophysical
Research Communications 210, 518523.
Mushegian AR, Koonin EV. 1995. A putative FAD-binding
domain in a distinct group of oxidases including a protein
involved in plant development. Protein Science 4, 12431244.
Nomura T, Nakayama M, Reid JB, Takeuchi Y, Yokota T.
1997. Blockage of brassinosteroid biosynthesis and sensitivity
causes dwarfism in garden pea. Plant Physiology 113, 3137.
Oh M-H, Romanow WG, Smith RC, Zamski E, Sasse J, Clouse
SD. 1998. Soybean BRU1 encodes a functional xyloglucan
endotransglycosylase that is highly expressed in inner epicotyl
tissues during brassinosteroid-promoted elongation. Plant
and Cell Physiology 39, 124130.
Russell DW, Wilson JD. 1994. Steroid 5a-reductases: two
genes/two enzymes. Annual Review of Biochemistry 63, 2661.
Sakai H, Hua J, Chen QG, Chang C, Medrano LJ, Bleecker
AB, Meyerowitz EM. 1998. ETR2 is an ETR1-like gene
involved in ethylene signalling in Arabidopsis. Proceedings of
the National Academy of Sciences, USA 95, 58125817.
Song W-Y, Wang G-L, Chen L-L, Kim H-S, Pi L-Y, Holsten T,
Gardner J, Wang B, Zhao W-X, Zhu L-H, Fauquet C, Ronald
P. 1995. A receptor kinase-like protein encoded by the rice
disease resistance gene, Xa21. Science 270, 18041806.
Stone JM, Collinge MA, Smith RD, Horn MA, Walker JC.
1994. Interaction of a protein phosphatase with an Arabidopsis
serine-threonine receptor kinase. Science 266, 793795.
Susek R, Ausubel FM, Chory J. 1993. Signal transduction
mutants of Arabidopsis uncouple nuclear CAB and RBCS
gene expression from chloroplast development. Cell 74,
Szekeres M, Nemeth K, Koncz-Kalman Z, Mathur J,
Kauschmann A, Altmann T, Redei GP, Nagy F, Schell J,
Koncz C. 1996. Brassinosteroids rescue the deficiency of
CYP90, a cytochrome P450, controlling cell elongation and
de-etiolation in Arabidopsis. Cell 85, 171182.